Diphtheria Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults
Condition:   Typhoid Fever Interventions:   Biological: TYP04A Low Dose without adjuvant investigational vaccine;   Biological: TYP04B Full Dose without adjuvant investigational vaccine;   Biological: TYP03A Low Dose adjuvanted investigational vaccine;   Biological: TYP03B Full Dose adjuvanted investigational vaccine;   Biological: Sa nofi Pasteur's Typhoid Vi polysaccharide vaccine;   Biological: GSK's Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine Sponsors:   GlaxoSmithKline;   Biological E. Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2022 Category: Research Source Type: clinical trials